SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000319
Filing Date
2021-01-06
Accepted
2021-01-06 06:15:21
Documents
14
Period of Report
2020-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rdus-8k_20201230.htm   iXBRL 8-K 45222
2 EX-99.1 rdus-ex991_6.htm EX-99.1 33408
3 GRAPHIC g53x5pmadtze000001.jpg GRAPHIC 3315
  Complete submission text file 0001564590-21-000319.txt   223508

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rdus-20201230.xsd EX-101.SCH 5788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rdus-20201230_lab.xml EX-101.LAB 19473
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rdus-20201230_pre.xml EX-101.PRE 11639
7 EXTRACTED XBRL INSTANCE DOCUMENT rdus-8k_20201230_htm.xml XML 3552
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

IRS No.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35726 | Film No.: 21508950
SIC: 2834 Pharmaceutical Preparations